Partner Content

R&D

Partner Content

7th Obesity & NASH Drug Development Summit

Reuniting metabolic experts to enable the assessment of the competitive landscape, the 7th Obesity & NASH Drug Development Summit is your exclusive industry meeting to:

R&D

Partner Content

Antifibrotic Drug Development Summit

As fibrosis stakeholders invest in bolstering their early pipeline to limit early candidate drop off, the 7th Antifibrotic Drug Development (AFDD) Summit explores actionable strategies to t

R&D

Partner Content

Champion Innovation at the 7th Dermatology Drug Development ...

Following 6 FDA approvals of JAK inhibitors and the breakthroughs of the first approved therapies in Prurigo Nodularis, Alopecia Areata and a gene therapy for Dystrophic Epidermolysis Bullo

R&D

Partner Content

2nd LNP Immunogenicity & Toxicity Summit

Back for its second iteration, the LNP Immunogenicity & Toxicity Summit (December 11-13, 2023 | Boston) will bring together 1

R&D

Partner Content

2nd TPD Assay Development & Screening Summit

Uniting Technical Personnel to Maximize Assay Workflows for Next Gen Protein Degraders

R&D

Partner Content

CRISPR-Based Therapy Analytical Development Summit

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.

7th Obesity & NASH Drug Development Summit

Antifibrotic Drug Development Summit

Champion Innovation at the 7th Dermatology Drug Development ...

2nd LNP Immunogenicity & Toxicity Summit

2nd TPD Assay Development & Screening Summit

CRISPR-Based Therapy Analytical Development Summit

Hims & Hers launches weight-loss business in UK

How to meet your physicians where they are online

Partner Content

Editor's Picks